Notice Regarding the Status of Repurchase of Shares
Filed with TSE · · 1 page · English
Rohto Pharmaceutical Co., Ltd. on 6ix
Story so far
Earlier from Rohto Pharmaceutical
- Notice Regarding Voluntary Recall of Vietnamese-Made Eye Drops in the United States
- Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2027 (Three Months Ended June 30, 2026)
- 【Delayed】Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2023
- Rohto Pharmaceutical: Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2022
- Rohto Pharmaceutical: Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2022
Later from Rohto Pharmaceutical
- Ono Pharma Enters into a Drug Discovery Partnership with Aitia in Neurological Diseases
- Notice Regarding the Status of Repurchase of Shares and Completion of Repurchase
- バージャー病、膠原病により生じる難治性虚血性(非動脈硬化性)下肢潰瘍に対するRE-01細胞治療の第II相医師主導治験を開始
- Management Strategy Briefing
- Medium- to Long-Term Growth Strategy 2026
Follow Rohto Pharmaceutical into a list and get an email when it puts out news.
Follow Rohto Pharmaceutical